Breathing innovation, empowering lives

Digilung, funded by the European Union, addresses the global health challenge caused by chronic obstructive pulmonary disease (COPD). DIGILUNG amplifies the product development and commercialization of three artificial intelligence-based health technologies, creating a comprehensive solution that integrates them and leads to a larger impact. The Atride SMPC’s (Kinetic Analysis) introduces the wearable LungShirt, recording daily respiratory and activity data sent to the MoveUp AI platform for analysis and recommendations. The state-of-the-art API platform by Cognuse integrates these technological solutions. Digilung is pioneering a new era in COPD treatment, fostering regional ecosystems, prioritizing a patient-centric approach, and enhancing the quality of life for those affected by the disease.